Status:

RECRUITING

Head Acupuncture Treat Residual Symptoms After Canalith Repositioning Procedure for BPPV

Lead Sponsor:

Xi'an No.3 Hospital

Conditions:

Benign Paroxysmal Positional Vertigo

Eligibility:

All Genders

18-65 years

Phase:

NA

Brief Summary

Benign paroxysmal positional vertigo (BPPV) is the most common peripheral vestibular disorder, and currently, manual repositioning techniques are often used for treatment. However, up to 30%-50% of pa...

Detailed Description

Research objectives: 1. Explore the risk factors that influence residual effects after BPPV and develop a predictive score chart. 2. Determine the gait characteristics of patients with residual effec...

Eligibility Criteria

Inclusion

  • According to the diagnostic criteria and therapeutic efficacy evaluation for benign paroxysmal positional vertigo (BPPV) formulated by the Otolaryngology-Head and Neck Surgery Branch of the Chinese Medical Association, the patient was confirmed as having BPPV and the repositioning maneuver was successful.
  • After the maneuver, the patient's clinical symptoms were relieved, with no sense of rotation or dizziness, but residual symptoms such as discomfort and unsteady gait persisted.
  • There were no obvious communication barriers or visual impairments.
  • The patient and their family members agreed to the treatment plan.

Exclusion

  • Patients with other ear diseases, history of head trauma or surgery;
  • Patients who are weak and unable to tolerate, pregnant women;
  • Patients who have undergone vestibular rehabilitation training before this treatment; ④ Patients with joint diseases that affect balance and walking; ⑤ Patients with a history of brain organic diseases (such as tumors, stroke, cerebral hemorrhage) or severe neurological diseases; ⑥ Patients with incomplete data or who withdraw from treatment midway.

Key Trial Info

Start Date :

November 1 2023

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

November 1 2026

Estimated Enrollment :

120 Patients enrolled

Trial Details

Trial ID

NCT06001047

Start Date

November 1 2023

End Date

November 1 2026

Last Update

December 15 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Xi'an No3 Hospital

Xi'an, China